efficiently delivered on a widespread basis. We believe that we can achieve that with MultiStemTM
," commented Dr. Van Bokkelen.
In extensive animal testing, the mature stem cells have been shown to be safe, and do not form tumors or other abnormal tissue, a potential problem seen with embryonic stem cells. Furthermore, MultiStemTM cells generally do not require the close genetic matching between donor and recipient that is needed for a bone marrow or conventional stem cell transplant, according to company executives.
Another advantage is that use of immunosuppressive drugs does not appear to be required, in contrast to other types of stem cell treatment. Animals that received MultiStemTM without immunosuppression of any kind did just as well as animals that received MultiStemTM treatment along with daily doses of Cyclosporine A, a drug typically given to transplant recipients to prevent rejection. Such drugs can cause undesired side effects, and may be problematic if administered to patients for long periods of time. These results are consistent with those seen in other models, such as using MultiStemTM to treat damage caused by heart attacks, company officials say.
Although they have not specifically looked at whether stem cell therapy might be useful months after an ischemic event, MCG researchers and company scientists believe early therapy likely will be the most successful.
The researchers already are working with the Food and Drug Adminstration with the goal of beginning clinical trials within the next few years.
In preparation for potential clinical use, the researchers are pursuing transplants in larger animal models and studying how MultiStemTM cells work in living human brain tissue housed at the MCG Human Brain Bank, directed by Dr. Sergei Kirov.
"Number one is safety," said Dr. Borlongan. "We are moving moPage: 1 2 3 4 5 Related biology news :1
Source:Medical College of Georgia
. Pennsylvania researchers find liver transplants provide metabolic cure for rare genetic disease2
. Predicting successful outcomes in living-donor liver transplants3
. What animals can tell us about hemorrhage, organ transplants and aging4
. Leading reason for corneal transplants comes into focus5
. Protein may hold key to decreasing organ dysfunction rates in heart transplants6
. Stem cell transplants explored at Stanford as a possible treatment for hearing loss7
. Thymus transplants gives hope to babies with fatal immune disease8
. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine9
. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells10
. Vascular structure and function improve with diet and exercise11
. Scientists discuss improved biopesticides for locust control in West Africa